HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Waldiceu A Verri Selected Research

2,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)

6/2021The diterpene from Sphagneticola trilobata (L.) Pruski, kaurenoic acid, reduces lipopolysaccharide-induced peritonitis and pain in mice.
6/2018Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation.
6/2017Trans-chalcone added in topical formulation inhibits skin inflammation and oxidative stress in a model of ultraviolet B radiation skin damage in hairless mice.
4/2016Topical formulation containing hesperidin methyl chalcone inhibits skin oxidative stress and inflammation induced by ultraviolet B irradiation.
9/2014Pyrrolidine dithiocarbamate inhibits UVB-induced skin inflammation and oxidative stress in hairless mice and exhibits antioxidant activity in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Waldiceu A Verri Research Topics

Disease

78Inflammation (Inflammations)
11/2021 - 06/2006
77Pain (Aches)
12/2022 - 11/2005
71Hyperalgesia
12/2022 - 11/2005
43Edema (Dropsy)
03/2022 - 09/2008
29Arthritis (Polyarthritis)
05/2022 - 08/2004
13Infections
06/2021 - 06/2010
9Necrosis
01/2022 - 05/2007
9Rheumatoid Arthritis
11/2021 - 06/2006
8Gout
01/2022 - 05/2017
8Experimental Arthritis
01/2020 - 06/2008
6Sunburn
11/2021 - 01/2018
6Chronic Pain
07/2021 - 03/2010
6Neoplasms (Cancer)
06/2016 - 08/2006
5Neuralgia (Stump Neuralgia)
01/2020 - 01/2016
4Peritonitis
01/2022 - 04/2015
4Colitis
01/2021 - 02/2013
4Hypersensitivity (Allergy)
08/2020 - 11/2008
3Gouty Arthritis
01/2022 - 01/2018
3Wounds and Injuries (Trauma)
01/2021 - 10/2006
3Rheumatic Diseases (Rheumatism)
01/2020 - 05/2012

Drug/Important Bio-Agent (IBA)

78CytokinesIBA
12/2022 - 11/2005
37Analgesics (Analgesic Drugs)IBA
01/2022 - 08/2007
30Peroxidase (Myeloperoxidase)IBA
03/2022 - 06/2008
26AntioxidantsIBA
11/2021 - 07/2006
24CarrageenanIBA
12/2022 - 10/2010
21Superoxides (Superoxide)IBA
06/2021 - 10/2013
15Acetic Acid (Vinegar)FDA LinkGeneric
01/2021 - 05/2012
14QuercetinIBA
11/2021 - 01/2007
14Messenger RNA (mRNA)IBA
01/2021 - 04/2012
13FlavonoidsIBA
01/2021 - 10/2013
12Freund's AdjuvantIBA
12/2022 - 04/2013
12AntigensIBA
01/2022 - 07/2007
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 11/2005
11Formaldehyde (Formol)FDA Link
12/2022 - 04/2013
11ZymosanIBA
01/2022 - 06/2006
10ChemokinesIBA
01/2020 - 10/2006
9phenylbenzoquinoneIBA
12/2022 - 05/2012
9CollagenIBA
05/2022 - 01/2018
9LipopolysaccharidesIBA
01/2022 - 08/2013
9LipidsIBA
01/2022 - 02/2015
9Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2021 - 09/2014
9Etanercept (Enbrel)FDA Link
09/2021 - 04/2014
9Interleukin-33IBA
01/2021 - 06/2010
9Chalcone (Benzalacetophenone)IBA
01/2021 - 02/2015
9Endothelins (Endothelin)IBA
01/2017 - 11/2005
8prolinedithiocarbamate (PDTC)IBA
09/2021 - 09/2014
8Interleukin-6 (Interleukin 6)IBA
08/2021 - 02/2015
8naringeninIBA
12/2019 - 07/2015
7Uric Acid (Urate)IBA
01/2022 - 05/2017
7InflammasomesIBA
12/2019 - 03/2015
7KATP ChannelsIBA
08/2017 - 05/2012
6Interleukin-10 (Interleukin 10)IBA
01/2022 - 02/2015
6Capsaicin (Zostrix)FDA Link
01/2022 - 04/2013
6Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 11/2009
6Opioid Analgesics (Opioids)IBA
01/2020 - 04/2011
6Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 08/2013
6Glutathione (Reduced Glutathione)IBA
01/2018 - 10/2013
6Morphine (MS Contin)FDA LinkGeneric
02/2015 - 11/2005
6ProstaglandinsIBA
01/2014 - 05/2007
5pyrrolidine dithiocarbamic acidIBA
09/2021 - 09/2014
52,2'- azino- di- (3- ethylbenzothiazoline)- 6- sulfonic acid (ABTS)IBA
06/2021 - 09/2014
5HesperidinIBA
01/2021 - 02/2015
5InterleukinsIBA
12/2020 - 08/2004
5vinpocetineIBA
01/2019 - 01/2015
5Type I Tumor Necrosis Factor ReceptorsIBA
04/2017 - 04/2014
5Interleukin-17 (Interleukin 17)IBA
04/2013 - 04/2009
4OvalbuminIBA
01/2022 - 12/2007
4Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2022 - 04/2014
4Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
09/2021 - 07/2014
4LigandsIBA
12/2020 - 02/2010
4Pharmaceutical PreparationsIBA
06/2020 - 08/2007
4Type II Tumor Necrosis Factor ReceptorsIBA
05/2019 - 09/2015
4Proteoglycans (Proteoglycan)IBA
12/2018 - 01/2017
4budlein AIBA
01/2018 - 05/2007
4oxyhyponitriteIBA
01/2017 - 08/2013
4nitroxylIBA
01/2017 - 08/2013
4Dinoprostone (PGE2)FDA Link
01/2016 - 07/2008
4Indomethacin (Indometacin)FDA LinkGeneric
02/2015 - 11/2005
4Leukotriene B4IBA
02/2015 - 12/2007
4Interleukin-18 (Interleukin 18)IBA
10/2010 - 07/2007
3titanium dioxide (Titania)FDA Link
05/2022 - 01/2018
3Biological ProductsIBA
03/2022 - 10/2016
3kaurenoic acidIBA
01/2022 - 05/2012
3Free RadicalsIBA
11/2021 - 07/2006
3Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
09/2021 - 02/2015
3Matrix Metalloproteinases (MMPs)IBA
03/2021 - 02/2010
3Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2011
3Toll-Like Receptors (Toll-Like Receptor)IBA
12/2020 - 01/2012
3Urea (Carbamide)FDA LinkGeneric
01/2020 - 06/2017
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2019 - 04/2011
3Probucol (Lorelco)FDA Link
08/2019 - 07/2017
3Acetaminophen (Paracetamol)FDA LinkGeneric
03/2019 - 01/2013
3potassium superoxideIBA
01/2019 - 09/2015
3Nootropic Agents (Nootropics)IBA
01/2019 - 04/2013
3Adenosine Triphosphate (ATP)IBA
01/2019 - 08/2013

Therapy/Procedure

17Therapeutics
01/2022 - 11/2005
4Analgesia
07/2021 - 08/2014
3Prostheses and Implants (Prosthesis)
05/2022 - 01/2018
3Traditional Medicine (Folk Remedies)
01/2022 - 01/2016
3Aftercare (After-Treatment)
01/2021 - 08/2017